|
|
Q&A series with Renal Fellows Network deputy editor: Using social media to ... - Scope (blog) |
Scope (blog)
One such example is the Renal Fellows Network, a research-related nephrology blog. In a three-part Q&A series this week, Stanford Nephrology Fellow and Renal Fellows Network deputy editor Graham Abra, MD, discusses how he and colleagues are using
|
|
|
Managing the patient with T2DM with RI - Clinical Advisor |
Clinical Advisor
Lowering BP in type 2 diabetics with hypertension has been shown to stabilize renal function. Approximately 24 million Americans have type 1 or type 2 diabetes mellitus (DM), and this number is expected to increase to 44 million by 2034.
|
|
More Upside for Watson Pharmaceuticals ? - TradersHuddle.com |
TradersHuddle.com
The Company's core focus is specialty products, nephrology, urology, and generic products. Watson Pharmaceuticals is currently trading 2.37% versus its previous trading session close, and it has calculated support and resistance at $53.73 and $57.45
|
|
Ofloxacin May Prevent UTIs in Renal Graft Recipients - Renal and Urology News |
Renal and Urology News
Prophylactic antibiotic with ofloxacin (OFLO) may significantly decrease the one-year incidence of urinary tract infections (UTIs) and acute pyelonephritis (APN) in renal transplant recipients, according to French researchers.
|
|
Lipid Management in Special Populations - Monthly Prescribing Reference |
Monthly Prescribing Reference
The use of statins in patients with renal insufficiency has primarily been studied in end-stage renal disease (ESRD), said Peter A. McCullough, MD, MPH, of Providence Park Healthcare System in Novi, MI. In general, statins increase proteinuria slightly
|
|
|
|
|
<< Start < Prev 981 982 983 984 985 986 987 988 989 990 Next > End >>
|
|
Page 982 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
